In vivo performance of absorbable collagen sponges with rosuvastatin in critical-size cortical bone defects

Acta Biomaterialia

Volumn 6, Issue 4, 2010, Pages 1405-1412

  Monjo, Marta ^a,c   Rubert, Marina ^a,c   Wohlfahrt, Johan Caspar ^a   Rønold, Hans Jacob ^b   Ellingsen, Jan Eirik ^b   Lyngstadaas, Staale Petter ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b Institute of Clinical Dentistry Pedodontics   (Norway)

^c UNIVERSITAT DE LES ILLES BALEARS   (Spain)

Author keywords

BMP 2 (bone morphogenetic protein 2); Collagen; In vivo bone growth; Statin; Titanium implant

Indexed keywords

COLLAGEN; COMPUTERIZED TOMOGRAPHY; DEFECTS; METAL IMPLANTS; PHOSPHATASES; TITANIUM;

BONE DEFECT; BONE GROWTH; BONE MORPHOGENETIC PROTEIN-2; COLLAGEN SPONGE; CORTICAL BONE; IN VIVO BONE GROWTH; IN-VIVO; STATINS; TITANIUM IMPLANTS;

BONE;

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 2; COLLAGEN SPONGE; ROSUVASTATIN; TITANIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE DEFECT; BONE DENSITY; BONE MINERALIZATION; BONE PLATE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORTICAL BONE; FEMALE; FRACTURE HEALING; GENE EXPRESSION; IN VIVO STUDY; MICRO-COMPUTED TOMOGRAPHY; NONHUMAN; OSSIFICATION; PRIORITY JOURNAL; RABBIT; SLOW DRUG RELEASE; TIBIA;

ANIMALIA; ORYCTOLAGUS CUNICULUS; RICE STRIPE VIRUS;

EID: 76949089977     PISSN: 17427061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actbio.2009.09.027     Document Type: Article

References (50)

1. Garrett I.R., Gutierrez G., and Mundy G.R. Statins and bone formation. Curr Pharm Des 7 8 (2001) 715-736
2. Liao J.K., and Laufs U. Pleiotropic effects of statins. Annu Rev Pharmacol Toxicol 45 (2005) 89-118
3. Tandon V., Bano G., Khajuria V., Parihar A., and Gupta S. Pleiotropic effects of statins. Indian J Pharmacol 37 2 (2005) 77-85
4. Grasser W.A., Baumann A.P., Petras S.F., Harwood Jr. H.J., Devalaraja R., Renkiewicz R., et al. Regulation of osteoclast differentiation by statins. J Musculoskelet Neuronal Interact 3 1 (2003) 53-62
5. Kaji H., Kanatani M., Sugimoto T., and Chihara K. Statins modulate the levels of osteoprotegerin/receptor activator of NFkappaB ligand mRNA in mouse bone-cell cultures. Horm Metab Res 37 10 (2005) 589-592
6. Staal A., Frith J.C., French M.H., Swartz J., Gungor T., Harrity T.W., et al. The ability of statins to inhibit bone resorption is directly related to their inhibitory effect on HMG-CoA reductase activity. J Bone Miner Res 18 1 (2003) 88-96
7. Hughes A., Rogers M.J., Idris A.I., and Crockett J.C. A comparison between the effects of hydrophobic and hydrophilic statins on osteoclast function in vitro and ovariectomy-induced bone loss in vivo. Calcif Tissue Int 81 5 (2007) 403-413
8. Ayukawa Y., Yasukawa E., Moriyama Y., Ogino Y., Wada H., Atsuta I., et al. Local application of statin promotes bone repair through the suppression of osteoclasts and the enhancement of osteoblasts at bone-healing sites in rats. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2008)
9. Baek K.H., Lee W.Y., Oh K.W., Tae H.J., Lee J.M., Lee E.J., et al. The effect of simvastatin on the proliferation and differentiation of human bone marrow stromal cells. J Korean Med Sci 20 3 (2005) 438-444
10. Maeda T., Matsunuma A., Kawane T., and Horiuchi N. Simvastatin promotes osteoblast differentiation and mineralization in MC3T3-E1 cells. Biochem Biophys Res Commun 280 3 (2001) 874-877
11. Maeda T., Matsunuma A., Kurahashi I., Yanagawa T., Yoshida H., and Horiuchi N. Induction of osteoblast differentiation indices by statins in MC3T3-E1 cells. J Cell Biochem 92 3 (2004) 458-471
12. Ruiz-Gaspa S., Nogues X., Enjuanes A., Monllau J.C., Blanch J., Carreras R., et al. Simvastatin and atorvastatin enhance gene expression of collagen type 1 and osteocalcin in primary human osteoblasts and MG-63 cultures. J Cell Biochem 101 6 (2007) 1430-1438
13. Song C., Guo Z., Ma Q., Chen Z., Liu Z., Jia H., et al. Simvastatin induces osteoblastic differentiation and inhibits adipocytic differentiation in mouse bone marrow stromal cells. Biochem Biophys Res Commun 308 3 (2003) 458-462
14. Mundy G., Garrett R., Harris S., Chan J., Chen D., Rossini G., et al. Stimulation of bone formation in vitro and in rodents by statins. Science 286 5446 (1999) 1946-1949
15. Gonyeau M.J. Statins and osteoporosis: a clinical review. Pharmacotherapy 25 2 (2005) 228-243
16. Jadhav S.B., and Jain G.K. Statins and osteoporosis: new role for old drugs. J Pharm Pharmacol 58 1 (2006) 3-18
17. Koida M., Fukuyama R., and Nakamuta H. Osteoporosis requires bone-specific statins. Curr Pharm Des 10 21 (2004) 2605-2613
18. Mundy G.R. Statins and their potential for osteoporosis. Bone 29 6 (2001) 495-497
19. Rizzo M., Di Fede G., Mansueto P., Castello F., Carmina E., and Rini G.B. Statins and osteoporosis: myth or reality?. Minerva Med 95 6 (2004) 521-527
20. Rogers M.J. Statins: lower lipids and better bones?. Nat Med 6 1 (2000) 21-23
21. Armitage J. The safety of statins in clinical practice. Lancet 370 9601 (2007) 1781-1790
22. Schachter M. Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update. Fundam Clin Phamacol 19 (2004) 9
23. Ayukawa Y., Okamura A., and Koyano K. Simvastatin promotes osteogenesis around titanium implants. Clin Oral Implants Res 15 3 (2004) 346-350
24. Oxlund H., and Andreassen T.T. Simvastatin treatment partially prevents ovariectomy-induced bone loss while increasing cortical bone formation. Bone 34 4 (2004) 609-618
25. Skoglund B., Forslund C., and Aspenberg P. Simvastatin improves fracture healing in mice. J Bone Miner Res 17 11 (2002) 2004-2008
26. Anbinder A.L., Junqueira J.C., Mancini M.N., Balducci I., Rocha R.F., and Carvalho Y.R. Influence of simvastatin on bone regeneration of tibial defects and blood cholesterol level in rats. Braz Dent J 17 4 (2006) 267-273
27. Gutierrez G.E., Lalka D., Garrett I.R., Rossini G., and Mundy G.R. Transdermal application of lovastatin to rats causes profound increases in bone formation and plasma concentrations. Osteoporos Int 17 7 (2006) 1033-1042
28. Seto H., Ohba H., Tokunaga K., Hama H., Horibe M., and Nagata T. Topical administration of simvastatin recovers alveolar bone loss in rats. J Periodontal Res 43 3 (2008) 261-267
29. Nyan M., Sato D., Oda M., Machida T., Kobayashi H., Nakamura T., et al. Bone formation with the combination of simvastatin and calcium sulfate in critical-sized rat calvarial defect. J Pharmacol Sci 104 4 (2007) 384-386
30. Moriyama Y., Ayukawa Y., Ogino Y., Atsuta I., and Koyano K. Topical application of statin affects bone healing around implants. Clin Oral Implants Res 19 6 (2008) 600-605
31. Stein D., Lee Y., Schmid M.J., Killpack B., Genrich M.A., Narayana N., et al. Local simvastatin effects on mandibular bone growth and inflammation. J Periodontol 76 11 (2005) 1861-1870
32. Thylin M.R., McConnell J.C., Schmid M.J., Reckling R.R., Ojha J., Bhattacharyya I., et al. Effects of simvastatin gels on murine calvarial bone. J Periodontol 73 10 (2002) 1141-1148
33. Ma B., Clarke S.A., Brooks R.A., and Rushton N. The effect of simvastatin on bone formation and ceramic resorption in a peri-implant defect model. Acta Biomater 4 1 (2008) 149-155
34. Wong R.W., and Rabie A.B. Statin collagen grafts used to repair defects in the parietal bone of rabbits. Br J Oral Maxillofac Surg 41 4 (2003) 244-248
35. Wong R.W., and Rabie A.B. Early healing pattern of statin-induced osteogenesis. Br J Oral Maxillofac Surg 43 1 (2005) 46-50
36. Wong R.W., and Rabie A.B. Histologic and ultrastructural study on statin graft in rabbit skulls. J Oral Maxillofac Surg 63 10 (2005) 1515-1521
37. Hamelin B.A., and Turgeon J. Hydrophilicity/lipophilicity: relevance for the pharmacology and clinical effects of HMG-CoA reductase inhibitors. Trends Pharmacol Sci 19 1 (1998) 26-37
38. Komai T., Shigehara E., Tokui T., Koga T., Ishigami M., Kuroiwa C., et al. Carrier-mediated uptake of pravastatin by rat hepatocytes in primary culture. Biochem Pharmacol 43 4 (1992) 667-670
39. Sakamoto K., Mikami H., and Kimura J. Involvement of organic anion transporting polypeptides in the toxicity of hydrophilic pravastatin and lipophilic fluvastatin in rat skeletal myofibres. Br J Pharmacol (2008)
40. Mikkaichi T., Suzuki T., Tanemoto M., Ito S., and Abe T. The organic anion transporter (OATP) family. Drug Metab Pharmacokinet 19 3 (2004) 171-179
41. Monjo et al. submitted for publication.
42. Friess W., Uludag H., Foskett S., Biron R., and Sargeant C. Characterization of absorbable collagen sponges as rhBMP-2 carriers. Int J Pharm 187 1 (1999) 91-99
43. Geiger M., Li R.H., and Friess W. Collagen sponges for bone regeneration with rhBMP-2. Adv Drug Deliv Rev 55 12 (2003) 1613-1629
44. Ronold H.J., and Ellingsen J.E. The use of a coin shaped implant for direct in situ measurement of attachment strength for osseointegrating biomaterial surfaces. Biomaterials 23 10 (2002) 2201-2209
45. Ruszczak Z., and Friess W. Collagen as a carrier for on-site delivery of antibacterial drugs. Adv Drug Deliv Rev 55 12 (2003) 1679-1698
46. Uludag H., Gao T., Porter T.J., Friess W., and Wozney J.M. Delivery systems for BMPs: factors contributing to protein retention at an application site. J Bone Joint Surg Am 83-A Suppl. 1 (Pt 2) (2001) S128-S135
47. Sugiyama M., Kodama T., Konishi K., Abe K., Asami S., and Oikawa S. Compactin and simvastatin, but not pravastatin, induce bone morphogenetic protein-2 in human osteosarcoma cells. Biochem Biophys Res Commun 271 3 (2000) 688-692
48. Monjo M., Lamolle S., Ellingsen J.E., Ronold H.J., and Lyngstadaas S.P. Markers for early implant performance correlating with bonding strength between titanium implants and bone. J Bone Miner Res 20 9 (2005) S113
49. Piattelli A., Scarano A., and Piattelli M. Detection of alkaline and acid phosphatases around titanium implants: a light microscopical and histochemical study in rabbits. Biomaterials 16 17 (1995) 1333-1338
50. Ruffoni D., Fratzl P., Roschger P., Phipps R., Klaushofer K., and Weinkamer R. Effect of temporal changes in bone turnover on the bone mineralization density distribution: a computer simulation study. J Bone Miner Res 23 12 (2008) 1905-1914